|
| |
| Drug Development |
|
ReceptoPharm is developing proprietary
therapeutic protein products for the treatment of neurological,
viral and and autoimmune disorders. |
| »
Learn More |
|
|
| |
| CRO Services |
ReceptoPharm offers a full range of contract
research services catering to small and start-up biotech companies. |
| » Learn More |
|
|
|
Below you will find the most recent ReceptoPharm
press releases. To view press releases from
previous years, please visit the Archives.
July 28, 2010
Nutra Pharma Receives Patent for Novel Antiviral Treatment using Modified Cobra Venom
July 22, 2010
Nutra Pharma Drug Discovery Subsidiary to Introduce Novel Antiviral Therapy at the International AIDS Conference in Vienna, Austria
June 23, 2010
Nutra Pharma Begins Drug Registration Process in Central America for its Nyloxin Pain Reliever
June 10, 2010
Nutra Pharma Announces Grupo Farmaceutico de Tijuana as its Exclusive Nyloxin Distributor in Mexico
June 01, 2010
Nutra Pharma Partners with Henry Schein for Distribution of Nyloxin-Branded Pain Relievers
May 25, 2010
Nutra Pharma Announces First Manufacturing Release of Nyloxin Rx, a Prescription Treatment for Chronic Pain
March 30, 2010
Over-the-Counter Pain Reliever, Cobroxin, Now Available in CVS
March 25, 2010
Nutra Pharma to Present and Exhibit at Upcoming Investment Conferences in Vancouver, Canada, and Las Vegas, Nevada
February 02, 2010
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin
December 07, 2009
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain
|
|
|
|
| |
| E-Alerts
|
| Signup to receive news and announcements
from ReceptoPharm and Nutra Pharma: |
|
|
|
|
|
|
|
